Welcome to our dedicated page for Nano-X Imaging Ltd. SEC filings (Ticker: NNOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Nanox Imaging Ltd’s journey from novel nanotechnology to FDA-cleared X-ray systems means diving into dense disclosures that mingle medical-device regulations with subscription-style revenue models. Locating R&D spending, approval milestones, or executive stock sales inside a 300-page document can feel overwhelming. That’s why investors searching for "Nanox insider trading Form 4 transactions" or "how to read a Nanox annual report 10-K" start here.
Stock Titan’s AI breaks down every Nanox filing in real time. Need the latest "Nanox quarterly earnings report 10-Q filing"? We post it within minutes of hitting EDGAR and pair it with plain-English summaries that spotlight cost-per-scan economics, cloud-service adoption, and regulatory risk updates. Curious about material events? Our platform tags each 8-K so you can skim "Nanox 8-K material events explained" instead of scrolling line by line. Insider activity is equally transparent: receive "Nanox Form 4 insider transactions real-time" alerts to monitor executive buys and sells the moment they’re reported.
Here’s what you’ll find on this page:
- AI-powered digests that make "understanding Nanox SEC documents with AI" effortless
- Side-by-side views of the full text and concise takeaways for every 10-K, 10-Q, and 8-K
- Filters for "Nanox proxy statement executive compensation" details and governance votes
- Instant notifications on "Nanox executive stock transactions Form 4" to track insider sentiment
- Historical archives for comparative "Nanox earnings report filing analysis" across quarters
Whether you’re evaluating commercialization progress or monitoring dilution risk, our comprehensive, continually updated feed ensures Nanox SEC filings are explained simply, accurately, and on your schedule.
Daniel Ran, listed as the Chief Financial Officer of Nano-X Imaging Ltd. (NNOX), reported a direct purchase of ordinary shares on 09/05/2025. The Form 4 shows he acquired 1,000 ordinary shares at a price of $3.65 per share and, following the transaction, beneficially owned 6,950 ordinary shares in total. The filing indicates this is an individual filing by one reporting person and includes no derivative transactions.
Daniel Ran filed an Initial Statement of Beneficial Ownership (Form 3) for Nano-X Imaging Ltd. (NNOX) dated 09/05/2025. The filing shows Mr. Ran is an officer (CFO) and a director and beneficially owns 5,950 ordinary shares directly. He also holds two option grants exercisable for ordinary shares: 40,000 options exercisable from 09/30/2022 and expiring 09/30/2031 with an exercise price of $23.86, and 55,000 options exercisable from 05/23/2024 and expiring 05/23/2033 with an exercise price of $11.52. The filing lists a Forest Hills, NY address for the reporting person and is signed by Daniel Ran on 09/05/2025.
FAQ
What is the current stock price of Nano-X Imaging Ltd. (NNOX)?
What is the market cap of Nano-X Imaging Ltd. (NNOX)?
